Best Life Sciences Platforms and Tools Companies in Bavaria, Germany
The 76 best Life Sciences Platforms and Tools companies in Bavaria, Germany in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Ingenium Pharamceutical.
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Bavaria
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Stage | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Ingenium Pharamceutical Discovering drug targets through Deductive Genomics | $71M | 242 mo ago | 41 | John Watkins President & CEO | — | Acquired | — | — |
| 2 | inveox Manufacturing automated laboratory solutions for biopsy sample preparation | $26M | 82 mo ago | 36 | Maria Driesel Co-Founder & CEO | — | Series A | 30 patents Automated histology sample preparation, imaging, and 3D pathology modeling systems. | — |
| 3 | ISAR Bioscience Developer of regenerative medicine | $23M | 31 mo ago | 19 | — | Master SliderWordPressMySQL+18 | Funding Raised | 15 patents Patents concentrated in chemistry & materials | — |
| 4 | GNA Biosolutions Develops instruments, OEM modules and assays for molecular pathogen detection | $20M | 82 mo ago | 29 | — | — | Series C | 96 patents Patents concentrated in chemistry & materials | — |
| 5 | PreOmics Provider of reagents and instruments for proteomics research | $19M | 53 mo ago | 22 | Nils Kulak Co-Founder & CEO | Webflow EcommerceWebflowSalesforce+17 | Series B | 59 patents Proteomics sample preparation and magnetic protein fractionation for mass spectrometry analysis | 1 job opening |
| 6 | PreciPoint Developer of digital microscopes and micro-positioning systems | $10M | 47 mo ago | 37 37 → 44 (+19%) · sector median +20% | Dominik Gerber Co-CEO | PHPMicrosoft 365Cloudflare Browser Insights+2 | Series A | 43 patents High‑resolution digital microscopy imaging, whole‑slide scanning, image archiving, and distributed analysis | 1 partnership |
| 7 | AMW Transdermal drug delivery technologies | $6M | 101 mo ago | 78 78 → 99 (+27%) · sector median +20% | Wilfried Fischer Founder | — | Acquired | 89 patents Controlled-release drug depots and implant delivery apparatus for pharmaceutical applications | — |
| 8 | Dynamic Biosensors Provides solutions for label-free molecular interaction and biophysical analysis | $6M | 45 mo ago | 51 51 → 62 (+22%) · sector median +20% | — | WordPressMySQLPHP+24 | Acquired | 33 patents Microfluidic cell immobilization and bubble control for protein‑small molecule biosensing | 1 launch |
| 9 | Kumovis Developer of 3D-printing systems | $5M | 72 mo ago | 20 | Sebastian Pammer Co-Founder | — | Acquired | 52 patents 3D‑printed orthopedic implants and additive manufacturing hardware for medical device production | — |
| 10 | IRUBIS Developer of analytical technology for real-time bioprocess monitoring and analysis | $3M | 21 mo ago | 15 15 → 20 (+33%) · sector median +20% | Lorenz Mirle Co-Founder | — | Seed | 8 patents Optical spectroscopy flow cells and disposable bioreactors for bioprocess monitoring | — |
| 11 | SAW Instrument Instruments for analyzing biomolecular interactions. | $1M | 183 mo ago | 11 | Stefan Duhr CEO | — | Acquired | — | — |
| 12 | Baseclick Holders of rights to new procedures in click chemistry and DNA photography. | $1M | 44 mo ago | 14 14 → 10 (-29%) · sector median +20% | — | Cart FunctionalityWooCommerceWordPress+26 | Series B | 119 patents Click‑chemistry platforms for modified mRNA synthesis and vaccine development | — |
| 13 | Nanion Technologies Develops Automated patch clamp system | $1M | 76 mo ago | 78 | — | WordPressMySQLPHP+40 | Funding Raised | 3 patents Ion‑channel electrophysiology platforms and microfluidic pressure‑control valve technology. | — |
| 14 | CASCAT Develops fine chemicals using bioprocess | $968K | 29 mo ago | — | Andre Pick Founder & Co-CEO | — | Funding Raised | 19 patents Patents concentrated in chemistry & materials | — |
| 15 | Intana Bioscience Provider of services in assay development and screening on FCCS | $908K | 81 mo ago | 8 | Frank Becker Co-Founder & MD | — | Seed | 10 patents High‑complexity siRNA library production and FCCS‑based biomolecular interaction analysis. | — |
| 16 | Crelux X-ray crystallography, fragment based drug discovery and protein delivery. | $863K | 134 mo ago | 68 | Michael Schaeffer Founder & Owner | Animate.cssBootstrapApache HTTP Server+7 | Acquired | — | — |
| 17 | NanoTemper Develops tools for protein characterization & analysis | $830K | 76 mo ago | 240 | Philipp Baaske Co-Founder & Co-CEO | WordPressApple iCloud MailMicrosoft 365+27 | Funding Raised | 8 patents Thermophoretic and optical analysis of particles in microfluidic capillary systems | 1 launch |
| 18 | Ibidi Products and reagents for cell-based assay and microscopy | $817K | 77 mo ago | — | Valentin Kahl CEO | PrestaShopMySQLZoho+22 | Funding Raised | 148 patents Microfluidic platforms for cell-based assays and microscopy sample handling. | 1 launch · 1 partnership |
| 19 | OmicScouts Mass spectrometry-based proteomics for drug and biomarker discovery | $658K | 74 mo ago | — | Hannes Hahne Co-Founder & CEO | PHPVimeoBootstrap+9 | Funding Raised | — | 1 partnership |
| 20 | Chromo Tek Offering immunologic research tools | $509K | 191 mo ago | 17 | — | — | Acquired | — | — |
| 21 | SIMFO Developer of analytics platform for cancer therapy | $366K | 79 mo ago | 12 | Ulrich Pachmann CEO & MD | — | Funding Raised | — | — |
| 22 | Loewe Biochemica Develops plant disease detection tools | $291K | 97 mo ago | — | Renate Loewe Founder & CEO | Cart FunctionalityWooCommerceWordPress+22 | Funding Raised | — | — |
| 23 | BioVariance Crowd-sourced platform for capture and analysis of drug dosage, adherence and adverse events | $260K | 77 mo ago | 18 | Josef Scheiber Founder & MD | Cart FunctionalityShopifyVisa+19 | Funding Raised | 2 patents Syringe‑compatible medicament delivery devices and associated usage systems | — |
| 24 | Vermicon Developer of a gene probe technology to diagnose microorganisms | $245K | 116 mo ago | 9 | Jiri Snaidr Founder & CEO | TYPO3 CMSPHPYouTube+8 | Funding Raised | 32 patents Rapid, specific detection methods for microorganisms, especially gram‑positive bacteria, in diagnostics. | — |
| 25 | PVA SPA Software Development Provider of automation software and systems for semiconductor production | $111K | 96 mo ago | — | Jalin Ketter CEO | TYPO3 CMSPHPUIKit+8 | Funding Raised | — | — |
| 26 | Spherotec Developing spheroid microtumor technology for use in drug development and therapy selection | $107K | 109 mo ago | 3 | Barbara Mayer Co-Founder & Co-CEO | — | Funding Raised | 15 patents Automated production and therapeutic testing of 3D cell spheroids for drug screening | — |
Top 12 Life Sciences Platforms and Tools companies in Bavaria
#1
Seed · Munich, Bavaria · founded 2017 · 15 employees$3.3Mraised▾
Developer of analytical technology for real-time bioprocess monitoring and analysis. It offers solutions for proteins, excipients, and nucleic acids in downstream processing. The technology provides real-time data, enabling faster decision-making and simplified bioprocess development. It utilizes mid-infrared spectroscopy for precise measurements and single-use flow cells to minimize contamination risks.
- Aug 2024Seed—
- Oct 2022Seed$2.8M
- Mar 2022Seed$550.4K
- May 2020Grant (prize money)$1.5M
#2
Funding Raised · Planegg, Bavaria · founded 2018 · 19 employees$23.1Mraised▾
ISAR Bioscience is the developer of regenerative medicine. The company uses the induced pluripotent stem cell and genome engineering technologies for developing regenerative medicine. It has collaboration with ldc and Assay.Works to develops therapeutic and discovery technology.
- Nov 2023Grant (prize money)$1M
- Grant (prize money)$22.1M
#3
Funding Raised · Straubing, Bavaria · founded 2014$967.7Kraised▾
CASCAT is engaged in the development of fine chemicals and specialties using bioprocessing. The company has engineered enzymes to scale up the process towards optimal process condition. The product portfolio of the company includes glucose-1-phosphate dipotassium salt, glucose-6-phosphate dipotassium salt, and other products. These products find application in chemical or pharmaceutical industry as well as analytical standards.
- Jan 2024Grant (prize money)$391.6K
- Mar 2023Grant (prize money)$277.9K
- Jan 2020Grant (prize money)$298.2K
#4
Series B · Munich, Bavaria · founded 2014 · 22 employees$19.1Mraised▾
Provider of reagents and instruments for proteomics research. The company currently manufactures sample preparation kits for reproducible preparation of clean peptide mixtures from any starting material and accessories for proteomics research. There is also a pre-fractionation system under development called SPIDER which the company claims, will be the first nano-flow fully automated peptide pre-fractionation device.
- Jan 2022Series B$15.4M
- Aug 2019Grant (prize money)$55.1K
- May 2019Grant (prize money)$56K
- Dec 2018Series A$3.7M
#5
Acquired · Planegg, Bavaria · founded 2011 · 51 employees$5.8Mraised▾
Dynamic Biosensors is a provider of instruments, consumables and services in the field of analytical systems for the characterization of biomolecules and molecular interactions. It has developed a patented switchSENSE technology, a biochip platform for the analysis of molecular interactions. Its products include DRX 2400 analyzer that controls the electrical actuation of biomolecules; Biochip 4x6 which features 24 microelectrodes. It also offers services related to interaction measurements, assay development and data analysis with the samples provided.
- Sep 2022Grant (prize money)$259.1K
- Jan 2019Grant (prize money)$289.7K
- Apr 2018Grant (prize money)$306.9K
- Jan 2018Grant (prize money)$300.8K
#6
Series A · Freising, Bavaria · founded 2018 · 37 employees$10.2Mraised▾
Developer of digital microscopes and micro-positioning systems. Its flagship product M8 offers the dual purpose of a remote-controllable microscope and whole slide scanner with a touch screen computer. The other products are automated optical and mechanical (testing) systems with custom-made software, micro-spectroscopy, microscopy x-y-stages, hardness testers, and electronic control systems. The company also offers cloud services for microscopic databases and telemicroscopy.
- Jul 2022Series A$10.2M
- 2019Seed—
#7
Acquired · Planegg, Bavaria · founded 1999 · 41 employees$71.3Mraised▾
Discovering drug targets through Deductive Genomics. The company has developed complementary biomedical technologies for both drug discovery and drug target validation. Ingenium has developed several drug discovery approaches based on a unique functional analysis of the mammalian genome at the organism level (Deductive Genomics). Its product includes NGENOtyping a novel, high-speed, genetics tool for in vivo validation of gene-based drug targets by providing the most rapid pathway to genetic mouse and rat models. The company is founded as a spin-off from the German Human Genome Project, is a subsidiary of the integrated drug development company Probiodrug.
- Apr 2006Series D$11.1M
- Apr 2005Grant (prize money)$1.4M
- Dec 2003Series C$16.9M
- Sep 2000Series B$43.3M
#8
Series A · Munich, Bavaria · founded 2017 · 36 employees$25.8Mraised▾
Inveox offers automated laboratory solutions for biopsy samples (transferring and labeling tissue samples, sample receipt, and encapsulation of biopsy samples. The company provides software for lab information management and gets the digitally linked relevant information using a QR-code. The company has designed an automated device for sample processing, management, sample container arrangement, and more.
- Aug 2019Series A$18.9M
- Oct 2018Grant (prize money)$5.7K
- Sep 2018Angel$5.8M
- Feb 2018Conventional Debt—
#9
Series B · Tutzing, Bavaria · founded 2008 · 14 employees$1.2Mraised▾
The baseclick technology is based on click chemistry method introduced by Professor Barry Sharpless (Nobel Prize in Chemistry, 2001) of The Scripps Research Institute, La Jolla, California. Professor Thomas Carell of Ludwig-Maximilians-Universität Munich, Germany, has advanced the technology so that nucleic acids can be efficiently modified. The basic patent on copper-catalyzed click reactions on nucleic acids was granted by the European Patent Office in 2010 followed by many other countries such as USA, Japan etc. The company which is spin off of BASF SE and Ludwig-Maximilians-Universität (LMU) hold the IP and licenses it along with providing support for further development.
- Oct 2022Grant (prize money)$255.4K
- Apr 2020Grant (prize money)$539.9K
- Apr 2018Grant (prize money)$306.9K
- Jan 2018Grant (prize money)$300.8K
#10
Series C · Planegg, Bavaria · founded 2010 · 29 employees$20.2Mraised▾
Develops instruments, OEM modules and assays for molecular pathogen detection. It claims its technology as a new approach to PCR along with cooling and heating rates at different orders and enables physicians and hospitals to diagnose bacterial diseases. Its first product Pharos400 features laser-based PCR technology is for thermal cycling and fluorescence-free real-time readout of results.
- Aug 2019Series C$13.5M
- Dec 2017Grant (prize money)$2M
- Jun 2015Series B$6.7M
#11
Acquired · Munich, Bavaria · founded 2017 · 20 employees$5.1Mraised▾
Kumovis develops 3D-printing systems for life science industries. The company has developed their product, KUMOVIS R1, which is based on Fused Filament Fabrication technology (3D printing process that uses a continuous filament of a thermoplastic material). Their main focus is to develop polymers such as polyether ether ketone.
- May 2020Series A$4M
- Oct 2018Seed$1.2M
- Jan 2017Grant (prize money)—
#12
Acquired · Warngau, Bavaria · founded 2008 · 78 employees$6.4Mraised▾
AMW develops and manufactures transdermal drug delivery technologies. Their products are active-ingredient patches and implants. They develop therapeutic solutions for oncology, neurology, dermatology and pain treatment.
- Jan 2018Conventional Debt$30.1M
- Nov 2017Conventional Debt$29.1M
- Jul 2016Series C$6.4M
- Aug 2014Series B—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics is moving in Germany
A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 2,605 Germany-affiliated papers.
- Heidelberg University245
- German Cancer Research Center123
- Charité - Universitätsmedizin Berlin95
- Goethe University Frankfurt94
- Ludwig-Maximilians-Universität München91
- Genome13→106
- Gene16→108
- Transcriptome6→61
- Epigenetics2→40
- Context (archaeology)1→33
- Disease1→62
- Gene3→49
- Immune system1→41
- Transcriptome4→37
- Biomarker1→29
- Disease2→41
- Immune system1→29
- Gene4→24
- Genome2→20
- Cancer1→14
Where bioinformatics is researched across Germany
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.